Inspire therapy is a small, fully implanted system that senses breathing patterns and delivers mild stimulation to maintain multilevel airway patency during sleep.
The Inspire system consists of three fully implanted components including a small generator, breathing sensor lead, and stimulation lead, all controlled with the small handheld Inspire sleep remote.
Thoughtful patient selection, selective stimulation of targeted airway muscles, and optimal stimulation timing all play an important role in maintaining airway patency and improving patient outcomes.
Inspire therapy is indicated for patients with the following characteristics: 22 years of age or older, have moderate to severe OSA (AHI range from 20-65 with <25% central apneas), unable to use CPAP, and free of complete concentric collapse at the palate. Inspire therapy has not been tested in people with BMI greater than 32.
The Inspire stimulation lead is designed to gently conform to a variety of hypoglossal (XII) nerve types. Securing the stimulation lead to the optimal location on the XII nerve facilitates stable, consistent stimulation of targeted airway muscles.
Using a proprietary algorithm, Inspire therapy continuously monitors the patient’s breathing patterns and delivers mild stimulation during inspiration, which is when the airway is most vulnerable to collapse.